NDC 15631-0552

CANTHARIS

Cantharis

CANTHARIS is a Oral Tablet in the Human Otc Drug category. It is labeled and distributed by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc. The primary component is Lytta Vesicatoria.

Product ID15631-0552_ab10654e-638d-4775-be7e-fe28f576ddc8
NDC15631-0552
Product TypeHuman Otc Drug
Proprietary NameCANTHARIS
Generic NameCantharis
Dosage FormTablet
Route of AdministrationORAL
Marketing Start Date2015-12-30
Marketing CategoryUNAPPROVED HOMEOPATHIC / UNAPPROVED HOMEOPATHIC
Labeler NameRxhomeo Private Limited d.b.a. Rxhomeo, Inc
Substance NameLYTTA VESICATORIA
Active Ingredient Strength3 [hp_X]/1
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 15631-0552-3

100 TABLET in 1 CONTAINER (15631-0552-3)
Marketing Start Date2015-12-30
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 15631-0552-1 [15631055201]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-0 [15631055200]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-7 [15631055207]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-5 [15631055205]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-6 [15631055206]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-2 [15631055202]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-3 [15631055203]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

NDC 15631-0552-4 [15631055204]

CANTHARIS TABLET
Marketing Categoryunapproved homeopathic
Product TypeHUMAN OTC DRUG
Marketing Start Date2015-12-30
Inactivation Date2020-01-31

Drug Details

Active Ingredients

IngredientStrength
LYTTA VESICATORIA3 [hp_X]/1

OpenFDA Data

SPL SET ID:0c45ac6c-5d5e-4c0d-8610-113df31beac5
Manufacturer
UNII
UPC Code
  • 8907460005526
  • NDC Crossover Matching brand name "CANTHARIS" or generic name "Cantharis"

    NDCBrand NameGeneric Name
    0220-1079CantharisLYTTA VESICATORIA
    0220-1082CantharisLYTTA VESICATORIA
    0220-1083CantharisLYTTA VESICATORIA
    0220-1088CantharisLYTTA VESICATORIA
    0220-1091CantharisLYTTA VESICATORIA
    0220-1092CantharisLYTTA VESICATORIA
    0220-1111CantharisLYTTA VESICATORIA
    0220-1114CantharisLYTTA VESICATORIA
    0220-1115CantharisLYTTA VESICATORIA
    0220-1145CantharisLYTTA VESICATORIA
    0360-0093CANTHARISCANTHARIS
    0360-0094CANTHARISCANTHARIS
    15631-0105CANTHARISCANTHARIS
    15631-0552CANTHARISCANTHARIS
    15631-2311CANTHARISCANTHARIS
    53645-1660CantharisCantharis
    54973-0609CANTHARISlytta vesicatoria
    54973-2909CANTHARISlytta vesicatoria
    60512-9151CANTHARISCANTHARIS
    62106-6607CANTHARISCantharides
    63083-7111CantharisCantharis
    68428-284CantharisLYTTA VESICATORIA
    71919-158CantharisLYTTA VESICATORIA
    76472-3010CantharisLYTTA VESICATORIA
    69152-1015Cantharis 200CCantharis
    69152-1213Cantharis 6CCantharis

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.